uniQure N.V.·4

Jun 12, 5:08 PM ET

Balachandran Madhavan 4

Research Summary

AI-generated summary

Updated

uniQure (QURE) Director Balachandran Madhavan Sells Shares, Receives RSUs

What Happened

  • Balachandran Madhavan, a director of uniQure N.V. (QURE), had three reported transactions: he was granted 7,550 restricted share units (RSUs) and a 13,980-share derivative award on 2026-06-10 (both reported at $0.00 acquisition price), and 1,993 shares were sold on 2026-06-11 in an open-market disposal for a weighted average price of $27.06, totaling $53,931. The sale was executed automatically to cover withholding taxes and was not a discretionary trade.

Key Details

  • Grant dates: 2026-06-10 — 7,550 RSUs (Acquired, $0.00); 2026-06-10 — 13,980 derivative award (Acquired, $0.00).
  • Sale date: 2026-06-11 — 1,993 shares sold (Open market) at a weighted avg price of $27.06; total proceeds ~$53,931. Price range for the sale: $26.92–$27.25.
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Notable footnotes:
    • F1: 7,550 RSUs represent contingent rights to one ordinary share per RSU; vest 100% on the first anniversary of grant, subject to continued service.
    • F4: The 13,980 derivative award (stock option) vests 100% on the first anniversary of grant, subject to continued service.
    • F2: The 1,993 shares were sold automatically upon RSU vesting to cover estimated withholding taxes — not a discretionary sale.
    • F3: Weighted-average sale price reported; the filer can provide per-trade prices on request.
  • Filing timeliness: Form 4 filed 2026-06-12 for transactions on 2026-06-10 and 2026-06-11; appears timely (not indicated as late).

Context

  • The sale appears routine tax-withholding related to RSU vesting rather than a voluntary divestiture, so it is less indicative of a change in insider sentiment. The grants are subject to one-year cliff vesting; no immediate exercise or cashless sale of options is reported.